Oppenheimer & Co’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.9M Sell
30,819
-3,544
-10% -$448K 0.05% 382
2025
Q1
$4.4M Sell
34,363
-12,998
-27% -$1.66M 0.07% 322
2024
Q4
$6.26M Buy
47,361
+11,698
+33% +$1.55M 0.09% 231
2024
Q3
$5.19M Buy
35,663
+237
+0.7% +$34.5K 0.08% 283
2024
Q2
$4.86M Sell
35,426
-321
-0.9% -$44.1K 0.08% 285
2024
Q1
$4.91M Buy
35,747
+2,532
+8% +$347K 0.08% 270
2023
Q4
$4.51M Buy
33,215
+1,273
+4% +$173K 0.08% 275
2023
Q3
$3.91M Sell
31,942
-519
-2% -$63.5K 0.08% 284
2023
Q2
$4.12M Sell
32,461
-2,463
-7% -$313K 0.08% 272
2023
Q1
$4.51M Buy
34,924
+2,842
+9% +$367K 0.1% 249
2022
Q4
$4.21M Sell
32,082
-3,659
-10% -$480K 0.1% 253
2022
Q3
$4.18M Buy
35,741
+8,513
+31% +$996K 0.1% 251
2022
Q2
$3.2M Buy
27,228
+5,053
+23% +$594K 0.07% 337
2022
Q1
$2.89M Sell
22,175
-1,106
-5% -$144K 0.05% 406
2021
Q4
$3.55M Buy
23,281
+2,448
+12% +$374K 0.06% 353
2021
Q3
$3.37M Buy
20,833
+558
+3% +$90.2K 0.06% 349
2021
Q2
$3.32M Buy
20,275
+519
+3% +$84.9K 0.06% 367
2021
Q1
$2.97M Sell
19,756
-3,325
-14% -$501K 0.06% 360
2020
Q4
$3.5M Buy
23,081
+1,066
+5% +$161K 0.07% 302
2020
Q3
$2.98M Sell
22,015
-37,464
-63% -$5.07M 0.07% 303
2020
Q2
$8.13M Buy
59,479
+32,042
+117% +$4.38M 0.21% 95
2020
Q1
$2.96M Sell
27,437
-7,996
-23% -$861K 0.09% 248
2019
Q4
$4.27M Sell
35,433
-902
-2% -$109K 0.11% 215
2019
Q3
$3.62M Sell
36,335
-4,012
-10% -$399K 0.1% 226
2019
Q2
$4.4M Sell
40,347
-2,889
-7% -$315K 0.12% 197
2019
Q1
$4.83M Buy
43,236
+15,168
+54% +$1.7M 0.13% 174
2018
Q4
$2.71M Sell
28,068
-5,847
-17% -$564K 0.08% 269
2018
Q3
$4.14M Buy
33,915
+2,323
+7% +$283K 0.11% 209
2018
Q2
$3.47M Sell
31,592
-11,760
-27% -$1.29M 0.09% 246
2018
Q1
$4.63M Sell
43,352
-2,347
-5% -$251K 0.12% 188
2017
Q4
$4.88M Sell
45,699
-2,925
-6% -$312K 0.13% 193
2017
Q3
$5.41M Buy
48,624
+7,890
+19% +$877K 0.14% 165
2017
Q2
$4.21M Sell
40,734
-447
-1% -$46.2K 0.12% 216
2017
Q1
$4.03M Sell
41,181
-8,229
-17% -$804K 0.11% 220
2016
Q4
$4.37M Sell
49,410
-20,631
-29% -$1.83M 0.13% 183
2016
Q3
$6.76M Buy
70,041
+20,736
+42% +$2M 0.2% 113
2016
Q2
$4.23M Buy
49,305
+15,951
+48% +$1.37M 0.13% 186
2016
Q1
$2.9M Sell
33,354
-47,883
-59% -$4.16M 0.09% 260
2015
Q4
$9.16M Buy
81,237
+1,155
+1% +$130K 0.27% 84
2015
Q3
$8.1M Buy
80,082
+20,175
+34% +$2.04M 0.25% 95
2015
Q2
$7.37M Buy
59,907
+4,959
+9% +$610K 0.21% 112
2015
Q1
$6.29M Buy
54,948
+18,513
+51% +$2.12M 0.17% 140
2014
Q4
$3.68M Sell
36,435
-17,811
-33% -$1.8M 0.11% 232
2014
Q3
$4.95M Sell
54,246
-4,209
-7% -$384K 0.15% 159
2014
Q2
$5.01M Sell
58,455
-17,379
-23% -$1.49M 0.15% 160
2014
Q1
$5.98M Buy
75,834
+1,149
+2% +$90.5K 0.18% 141
2013
Q4
$5.65M Buy
74,685
+1,962
+3% +$149K 0.18% 140
2013
Q3
$5.08M Buy
72,723
+4,698
+7% +$328K 0.18% 146
2013
Q2
$3.94M Buy
+68,025
New +$3.94M 0.15% 172